SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 651.80-0.3%Oct 31 9:30 AM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: A.J. Mullen who wrote (3474)9/8/2022 6:35:34 PM
From: Miljenko Zuanic1 Recommendation

Recommended By
bmaz001

  Read Replies (1) of 3557
 
This is good news, bring more hope for those hard to treat amd/dme conditions. Also option for 1/2 dose if it can be diluted properly can further solidify Eylea positions on this market. Roche (and others) are cooked!
If cancer field can move forward in REGN favor for costimulatory, 1000 stock price (my dream) is in reach.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News